Canada markets closed

Enveric Biosciences, Inc. (ENVB)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.8806-0.0574 (-6.12%)
At close: 04:00PM EDT
0.8960 +0.02 (+1.75%)
After hours: 07:49PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Gross Profit
-
-
-
0
0
Operating Expenses
Research Development
8,627
7,252
8,028
4,789
174.083
Selling General and Administrative
18,418
10,700
11,606
20,499
5,322
Total Operating Expenses
27,459
18,297
19,961
25,945
5,617
Operating Income or Loss
-27,459
-18,297
-19,961
-25,945
-5,617
Interest Expense
10.239
-
5.249
10.316
445.25
Total Other Income/Expenses Net
-31,884
1,030
9.3
-30,477
-802.109
Income Before Tax
-59,354
-17,263
-19,957
-56,432
-6,865
Income Tax Expense
28.913
28.913
-1,486
-7,455
0
Income from Continuing Operations
-51,899
-17,292
-18,471
-48,977
-6,865
Net Income
-51,919
-17,311
-18,504
-48,977
-6,865
Net Income available to common shareholders
-52,104
-17,459
-18,800
-48,977
-6,865
Basic EPS
-11.51
-
-13.00
-103.69
-59.50
Diluted EPS
-11.51
-
-13.00
-103.69
-59.50
Basic Average Shares
2,109
-
1,446
472.343
115.071
Diluted Average Shares
2,109
-
1,446
472.343
115.071